(Q37182429)

30 September 2017

1 reference

title

Bayesian designs to account for patient heterogeneity in phase II clinical trials (English)

1 reference

30 September 2017

phase II clinical trial

0 references

1 reference

1

Peter F Thall

1 reference

30 September 2017

2

J Kyle Wathen

1 reference

30 September 2017

1 July 2008

1 reference

Current Opinion in Oncology

30 September 2017

1 reference

30 September 2017

20

1 reference

30 September 2017

4

1 reference

30 September 2017

407-411

1 reference

A case for Bayesianism in clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5555403

Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5555403

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5555403

Optimal two-stage designs for phase II clinical trials

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5555403

Accounting for patient heterogeneity in phase II clinical trials

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5555403

A geometric approach to comparing treatments for rapidly fatal diseases.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5555403

One- and two-stage designs for stratified phase II clinical trials

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5555403

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5555403

One-sample multiple testing procedure for phase II clinical trials

3 September 2018

1 reference

12 December 2020

Randomized discontinuation design: application to cytostatic antineoplastic agents

1 reference

12 December 2020

On the efficiency of targeted clinical trials

1 reference

12 December 2020

Incorporating toxicity considerations into the design of two-stage phase II clinical trials

1 reference

12 December 2020

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

12 December 2020

10.1097/CCO.0B013E328302163C

Identifiers

DOI

1 reference

30 September 2017

1 reference

PMC publication ID

5555403

30 September 2017

PubMed publication ID

18525336

1 reference

PMC publication ID

5555403